Vizimpro Drug Interactions
Currently displaying a list of 109 drugs known to interact with Vizimpro (dacomitinib).
- 24 major drug interactions
- 83 moderate drug interactions
- 2 minor drug interactions
Medications known to interact with Vizimpro
Note: Showing generic names only.
A
B
C
- carvedilol
- cemiplimab
- cevimeline
- chlorpheniramine
- chlorpromazine
- cimetidine
- clomipramine
- clozapine
- codeine
- cosibelimab
D
- darifenacin
- desipramine
- deucravacitinib
- deutetrabenazine
- dexfenfluramine
- dexlansoprazole
- dextroamphetamine
- dextromethorphan
- diphenhydramine
- donepezil
- dostarlimab
- doxepin
- doxepin topical
- doxorubicin
- doxorubicin liposomal
- duloxetine
- durvalumab
E
F
G
H
I
L
M
- maprotiline
- meclizine
- mesoridazine
- methamphetamine
- methotrimeprazine
- metoclopramide
- metoprolol
- mexiletine
- midodrine
- mirtazapine
N
O
P
- pantoprazole
- paroxetine
- pembrolizumab
- perphenazine
- pexidartinib
- pimozide
- pirfenidone
- pitolisant
- promethazine
- propafenone
- propoxyphene
- propranolol
- protriptyline
R
S
T
- tamoxifen
- tamsulosin
- tetrabenazine
- thioridazine
- timolol
- timolol ophthalmic
- tislelizumab
- tolterodine
- toripalimab
- tramadol
- trazodone
- tremelimumab
- trimipramine
V
Vizimpro disease interactions
There are 2 disease interactions with Vizimpro (dacomitinib) which include:
More about Vizimpro (dacomitinib)
- Vizimpro consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.